Predictors of tyrosine kinase inhibitor adherence trajectories in patients with newly diagnosed chronic myeloid leukemia
Author:
Affiliation:
1. The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA
2. Fred Hutchinson Cancer Research Center, Seattle, WA, USA
3. School of Medicine, University of Washington, Seattle, WA, USA
Abstract
Funder
National Institutes of Health
Publisher
SAGE Publications
Subject
Pharmacology (medical),Oncology
Link
http://journals.sagepub.com/doi/pdf/10.1177/1078155220970616
Reference30 articles.
1. Chronic myeloid leukemia stem cells
2. Noone AM, Howlader N, Cronin KA, et al. SEER Cancer Statistics Review, 1975–2015. National Cancer Institute, https://seer.cancer.gov/csr/1975_2015/ (2017, accessed 10 October 2019).
3. Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring
4. Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
5. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Temporal effect of imatinib adherence on time to remission in chronic myeloid leukemia patients;Journal of Oncology Pharmacy Practice;2023-11-13
2. Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence;Blood Advances;2023-07-03
3. Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication;Current Hematologic Malignancy Reports;2022-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3